Be a PRO & get up to 50% off on select brands. Explore Now

NCR-based Migsun Group achieves sales of Rs 80 crore in 21 days

The Group said that of the total sales, 97 units were in the 2 BHK category, 38 units from 3 BHK, and 26 units from the commercial segment.

Representative image

Representative image

NCR-based Migsun Group announced that it has sold over 150 units amounting to approximately Rs 80 crore in the period from April 22 till date. These included commercial and residential units located in Greater Noida and Raj Nagar Extension in Ghaziabad, the company said.

The Group said that of the total sales, 97 units were in the 2 BHK category, 38 units from 3 BHK, and 26 units from the commercial segment.

The Group has also launched the 'Pay Rs 1 lakh now rest after the lockdown scheme' which is applicable to all its projects.

Last year, the Group saw bookings of over 250 units amounting to a sale of approximately Rs 100 crore after the lockdown was announced until May 14, 2020.

Earlier, the group had announced that it was planning to take up five to seven stuck projects in Greater Noida and invest Rs 4,500 crore in their construction.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"The company is planning to take up five to seven such projects spread across 3 crore sq ft," Yash Miglani, managing director, Migsun Group had told Moneycontrol.

These projects will be developed under the joint venture and development management agreement model, Miglani had said.

The company is executing 16 projects, both residential and commercial, in various parts of Delhi and its suburbs.
Moneycontrol News
first published: May 17, 2021 07:05 pm

stay updated

Get Daily News on your Browser
Sections